Purchase Order 36C24825P0195

Award Date 11/1/24
Potential Completion Date 7/14/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33125, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducer devices and associated support services. The $33,165.82 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022. This contract enables the VA to efficiently...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.43 firm fixed-price delivery order contract is for the provision of Novocure's Optune medical devices, transducer arrays, rental equipment, and related support services to treat solid tumor cancers using the company's non-invasive Tumor Treating Fields (TTFields) technology. The contract is not...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price purchase order is for the delivery of Novocure's Optune transducers, device rentals, and associated support services to provide the company's Tumor Treating Fields (TTFields) cancer therapy to VA medical facilities. The award is not associated with a set-aside...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm fixed-price delivery order is for the rental of Optune transducers, which are part of Novocure's proprietary Tumor Treating Fields (TTFields) cancer therapy system. The contract does not utilize any set-aside designations. This delivery order is issued under Novocure's...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune device, a specialized cancer therapy technology utilizing Tumor Treating Fields (TTFields). The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order with a completion date of July 16, 2025. Novocure holds a significant...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, with a ceiling value of $16,582.91, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers. The contract is structured as a firm fixed-price delivery order and does...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award, valued at $16,582.91, is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. Optune is Novocure's proprietary Tumor Treating Fields...

This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $33,165.82 firm fixed-price purchase order is for the delivery of Novocure's Optune medical device system, including transducers, rental equipment, and associated support services.

The contract does not utilize a set-aside designation, likely due to the specialized nature of Novocure's cancer treatment technology. Novocure serves as the prime contractor, delivering its proprietary Tumor Treating Fields (TTFields) therapy directly to VA medical facilities nationwide. This contract award is part of Novocure's broader $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined procurement mechanism for the VA to obtain Novocure's innovative, non-invasive cancer treatment solutions for veteran patients.

Generated 7/1/25, 5:48 AM